Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
biotech
boston blog main
clinical trials
deals
fda
3
×
life sciences
national blog main
national top stories
3
×
boston top stories
new york blog main
new york top stories
novartis
rna interference
sanofi
abbvie
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
dicerna pharamceuticals
What
medicines
3
×
deal
drug
acquire
acquisitions
agreed
announced
billion
bio
brings
cash
caught
causing
ceo
cholesterol
collabs
company
compound
covid
daniel
dicerna
disease
eye
fda
gene
gilead
gilead’s
help
hepatitis
intended
introduce
ipo
medco
month
new
novartis
o’day
pay
pharma
pharmaceuticals
Language
unset
Current search:
medicines
×
" national top stories "
×
fda
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug